SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-104264
Filing Date
2021-08-12
Accepted
2021-08-12 17:16:36
Documents
1
Group Members
ADAMS STREET 2016 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2017 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2018 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2019 DIRECT GROWTH EQUITY FUND VII LPADAMS STREET GROWTH EQUITY FUND VII LPADAMS STREET VENTURE/GROWT

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2125012d1_sc13d.htm SC 13D 150326
  Complete submission text file 0001104659-21-104264.txt   152208
Mailing Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807
Business Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807 312-553-8486
ADAMS STREET PARTNERS LLC (Filed by) CIK: 0001193586 (see all company filings)

IRS No.: 364395178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92771 | Film No.: 211168707
SIC: 2836 Biological Products, (No Diagnostic Substances)